Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
A ALIMENTARY TRACT AND METABOLISM
A05 BILE AND LIVER THERAPY
A05A BILE THERAPY
A05AX Other drugs for bile therapy
A05AX04 Maralixibat chloride
D10952 Maralixibat chloride (JAN/USAN/INN) <US>
USP drug classification [BR:br08302]
Gastrointestinal Agents
Gastrointestinal Agents, Other
Maralixibat
D10952 Maralixibat chloride (JAN/USAN/INN)
Target-based classification of drugs [BR:br08310]
Transporters
Solute carrier family
SLC10
SLC10A2 (ASBT, IBAT)
D10952 Maralixibat chloride (JAN/USAN/INN) <US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D10952
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D10952
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D10952